The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects

NCT04829123 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG: HEC88473 injection
DRUG: Placebo

Sponsor

Dongguan HEC Biopharmaceutical R&D Co., Ltd.